Head-to-head · WeighScore
Ageless vs Tyde Wellness
By GLP-1 ScorecardUpdated
Score comparison
Tyde Wellness has the higher recorded score — 79.8/100 to 69.7/100.
Tyde Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tyde advertises compounded GLP-1 injections with online clinician review and follow-up support.
Before you choose
Before comparing the headline prices, the Ageless review and the Tyde Wellness review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Ageless vs VirtualCare2Go and Alan Meds vs Tyde Wellness compare each of them with another graded program, and the list of alternatives to Ageless ranks the programs closest to Ageless on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Direct Meds review covers one graded close to these two, at 77.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Ageless | Tyde Wellness |
|---|---|---|
| WeighScore | 69.7/100 | 79.8/100 |
| Grade | C | C+ |
| Site position | #127 | #39 |
| Semaglutide | Public injection page shows $99 for a month’s supply; continuing price unconfirmed | $88 starting price (compounded injection; billing interval unconfirmed) |
| Tirzepatide | Public injection page shows $149 for a month’s supply; continuing price unconfirmed | $125 starting price (compounded injection; billing interval unconfirmed) |
| Coverage | Varies by state | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
FDAWarning letter issued to Lovely Meds, Inc. dba Lovely Meds in September 2025. Try Ageless's own medical-oversight page identifies Lovely Meds, Inc. as the company that operates tryageless.com. The letter concerns lovelymeds.com, does not name tryageless.com, and FDA has not closed it out. See the FDA warning-letter database.
Strengths
- Separate public pages identify each injection and the weight-loss catalog lists oral tablet options
- The terms identify Pharmacy Hub as one possible dispensing partner and describe how to request a prescription transfer
- The terms explain how shorter plan prices are used to calculate early cancellation refunds
What to consider
- The public injection prices do not establish the amount of later charges or the total for a particular plan
- The terms retain a $40 non-TRT consultation fee once clinical review starts, including if a clinician declines to prescribe
- A prepaid plan can be repriced on early cancellation and fulfillment can make an order nonrefundable
Strengths
- Advertises a free consultation
- Publishes membership cancellation instructions
What to consider
- Headline prices do not specify the billing interval
- Refunds after renewal are discretionary under membership terms
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.